45 results
8-K
EX-10.2
APRE
Aprea Therapeutics Inc
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event
424B3
APRE
Aprea Therapeutics Inc
9 Feb 24
Prospectus supplement
12:00am
and under what circumstances we will pay additional amounts in respect of any tax, assessment or governmental charge and, if so, whether we will have
PRE 14A
88yu1vlrr ip
27 May 22
Preliminary proxy
5:00pm
8-K
EX-2.1
4gaqg
16 May 22
Entry into a Material Definitive Agreement
9:28pm
8-K
EX-10.1
63ias8u
16 May 22
Entry into a Material Definitive Agreement
9:28pm